Yin-Yuan Mo - Publications

Affiliations: 
Molecular Biology Microbiology and Biochemistry Southern Illinois University at Carbondale, Carbondale, IL 
Area:
Molecular Biology

100 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Zhao D, Wu K, Sharma S, Xing F, Wu SY, Tyagi A, Deshpande R, Singh R, Wabitsch M, Mo YY, Watabe K. Publisher Correction: Exosomal miR-1304-3p promotes breast cancer progression in African Americans by activating cancer-associated adipocytes. Nature Communications. 14: 327. PMID 36658149 DOI: 10.1038/s41467-023-36009-x  0.351
2022 Peng WX, Liu F, Jiang JH, Yuan H, Zhang Z, Yang L, Mo YY. N6-methyladenosine modified LINC00901 promotes pancreatic cancer progression through IGF2BP2/MYC axis. Genes & Diseases. 10: 554-567. PMID 37223505 DOI: 10.1016/j.gendis.2022.02.014  0.325
2022 Zhao D, Wu K, Sharma S, Xing F, Wu SY, Tyagi A, Deshpande R, Singh R, Wabitsch M, Mo YY, Watabe K. Exosomal miR-1304-3p promotes breast cancer progression in African Americans by activating cancer-associated adipocytes. Nature Communications. 13: 7734. PMID 36517516 DOI: 10.1038/s41467-022-35305-2  0.354
2021 Xing F, Zhao D, Wu SY, Tyagi A, Wu K, Sharma S, Liu Y, Deshpande R, Wang Y, Cleary J, Miller LD, Chittiboyina AG, Yalamanchili C, Mo YY, Watabe K. Epigenetic and post-transcriptional modulation of SOS1 can promote breast cancer metastasis through obesity-activated c-Met signaling in African American women. Cancer Research. PMID 33446575 DOI: 10.1158/0008-5472.CAN-19-4031  0.333
2020 Zhu Z, Huang J, Li X, Xing J, Chen Q, Liu R, Hua F, Qiu Z, Song Y, Bai C, Mo YY, Zhang Z. Gut microbiota regulate tumor metastasis via circRNA/miRNA networks. Gut Microbes. 1-16. PMID 32686598 DOI: 10.1080/19490976.2020.1788891  0.365
2020 Lei L, Cheng SH, Wang X, Mo Y, Zhou Y. Abstract P6-10-14: A new model to predict 10-year distant recurrence risk for operable endocrine-responsive breast cancer population Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-P6-10-14  0.324
2020 Peng W, Yang L, Mo Y. Abstract 4827: N6-Methyladenosine modification of LINC00901 promotes pancreatic cancer progression Cancer Research. 80: 4827-4827. DOI: 10.1158/1538-7445.Am2020-4827  0.414
2019 Hu X, Peng WX, Zhou H, Jiang J, Zhou X, Huang D, Mo YY, Yang L. IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader. Cell Death and Differentiation. PMID 31804607 DOI: 10.1038/S41418-019-0461-Z  0.456
2019 Peng WX, Koirala P, Zhang W, Ni C, Wang Z, Yang L, Mo YY. lncRNA RMST Enhances DNMT3 Expression through Interaction with HuR. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 31636039 DOI: 10.1016/J.Ymthe.2019.09.024  0.347
2019 Hu X, Jiang J, Ni C, Xu Q, Ye S, Wu J, Ge F, Han Y, Mo Y, Huang D, Yang L. HBV Integration-mediated Cell Apoptosis in HepG2.2.15. Journal of Cancer. 10: 4142-4150. PMID 31417659 DOI: 10.7150/Jca.30493  0.342
2019 Peng WX, He RZ, Zhang Z, Yang L, Mo YY. LINC00346 promotes pancreatic cancer progression through the CTCF-mediated Myc transcription. Oncogene. PMID 31391552 DOI: 10.1038/S41388-019-0918-Z  0.434
2019 He RZ, Luo DX, Mo YY. Emerging roles of lncRNAs in the post-transcriptional regulation in cancer. Genes & Diseases. 6: 6-15. PMID 30906827 DOI: 10.1016/J.Gendis.2019.01.003  0.401
2019 Yang L, Hu X, Mo YY. Acidosis promotes tumorigenesis by activating AKT/NF-κB signaling. Cancer Metastasis Reviews. PMID 30729352 DOI: 10.1007/S10555-019-09785-6  0.364
2018 Xing F, Liu Y, Wu SY, Wu K, Sharma S, Mo YY, Feng J, Sanders S, Jin G, Singh R, Vidi PA, Tyagi A, Chan MD, Ruiz J, Debinski W, et al. Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis. Cancer Research. PMID 30026327 DOI: 10.1158/0008-5472.Can-18-1102  0.421
2018 Li J, Peng W, Du L, Yang Q, Wang C, Mo YY. The oncogenic potentials and diagnostic significance of long non-coding RNA LINC00310 in breast cancer. Journal of Cellular and Molecular Medicine. PMID 29993199 DOI: 10.1111/Jcmm.13750  0.453
2017 Vallabhaneni KC, Penfornis P, Xing F, Hassler Y, Adams KV, Mo YY, Watabe K, Pochampally R. Stromal cell extracellular vesicular cargo mediated regulation of breast cancer cell metastasis via ubiquitin conjugating enzyme E2 N pathway. Oncotarget. 8: 109861-109876. PMID 29299114 DOI: 10.18632/Oncotarget.22371  0.476
2017 Peng WX, Huang JG, Yang L, Gong AH, Mo YY. Linc-RoR promotes MAPK/ERK signaling and confers estrogen-independent growth of breast cancer. Molecular Cancer. 16: 161. PMID 29041978 DOI: 10.1186/S12943-017-0727-3  0.404
2017 Peng WX, Koirala P, Mo YY. LncRNA-mediated regulation of cell signaling in cancer. Oncogene. PMID 28604750 DOI: 10.1038/Onc.2017.184  0.456
2017 Koirala P, Huang J, Ho TT, Wu F, Ding X, Mo YY. LncRNA AK023948 is a positive regulator of AKT. Nature Communications. 8: 14422. PMID 28176758 DOI: 10.1038/Ncomms14422  0.661
2017 Liu J, Peng WX, Mo YY, Luo D. MALAT1-mediated tumorigenesis. Frontiers in Bioscience (Landmark Edition). 22: 66-80. PMID 27814602  0.323
2017 Liu J, Peng W, Mo Y, Luo D. MALAT1-mediated tumorigenesis. Frontiers in Bioscience. 22: 66-80. DOI: 10.2741/4472  0.43
2017 Nguyen T, Parajuli P, Ahmad A, Singh P, Eragameddy S, Ramakrishnan G, Levy L, Ferrigno O, Mo Y, Pochampally R, Razzaque MS, Prunier C, Atfi A. Abstract B32: Restoration of beta cell mass as a synthetic lethal strategy to overcome oncogenic Kras-driven pancreatic ductal adenocarcinoma Molecular Cancer Therapeutics. 16. DOI: 10.1158/1538-8514.Synthleth-B32  0.307
2016 Vallabhaneni KC, Hassler MY, Abraham A, Whitt J, Mo YY, Atfi A, Pochampally R. Mesenchymal Stem/Stromal Cells under Stress Increase Osteosarcoma Migration and Apoptosis Resistance via Extracellular Vesicle Mediated Communication. Plos One. 11: e0166027. PMID 27812189 DOI: 10.1371/Journal.Pone.0166027  0.353
2016 Ho TT, Huang J, Zhou N, Zhang Z, Koirala P, Zhou X, Wu F, Ding X, Mo YY. Regulation of PCGEM1 by p54/nrb in prostate cancer. Scientific Reports. 6: 34529. PMID 27682980 DOI: 10.1038/Srep34529  0.643
2016 Villamizar O, Chambers CB, Mo YY, Torry DS, Hofstrand R, Riberdy JM, Persons DA, Wilber A. Data in support of transcriptional regulation and function of Fas-antisense long noncoding RNA during human erythropoiesis. Data in Brief. 7: 1288-95. PMID 27141526 DOI: 10.1016/J.Dib.2016.03.106  0.381
2016 Villamizar O, Chambers CB, Mo YY, Torry DS, Hofstrand R, Riberdy JM, Persons DA, Wilber A. Fas-antisense long noncoding RNA is differentially expressed during maturation of human erythrocytes and confers resistance to Fas-mediated cell death. Blood Cells, Molecules & Diseases. 58: 57-66. PMID 27067490 DOI: 10.1016/J.Bcmd.2016.03.002  0.405
2016 Liu H, Li J, Koirala P, Ding X, Chen B, Wang Y, Wang Z, Wang C, Zhang X, Mo YY. Long non-coding RNAs as prognostic markers in human breast cancer. Oncotarget. PMID 26942882 DOI: 10.18632/Oncotarget.7828  0.461
2016 Xu M, Bian S, Li J, He J, Chen H, Ge L, Jiao Z, Zhang Y, Peng W, Du F, Mo Y, Gong A. MeCP2 suppresses LIN28A expression via binding to its methylated-CpG islands in pancreatic cancer cells. Oncotarget. PMID 26910839 DOI: 10.18632/Oncotarget.7507  0.393
2016 Zhang Z, Zhou N, Huang J, Ho TT, Zhu Z, Qiu Z, Zhou X, Bai C, Wu F, Xu M, Mo YY. Regulation of androgen receptor splice variant AR3 by PCGEM1. Oncotarget. PMID 26848868 DOI: 10.18632/Oncotarget.7139  0.587
2016 Ho T, Mo Y. Abstract 957: Regulation of PCGEM1 in castration resistant prostate cancer Cancer Research. 76: 957-957. DOI: 10.1158/1538-7445.Am2016-957  0.438
2015 Gupta SC, Singh R, Asters M, Liu J, Zhang X, Pabbidi MR, Watabe K, Mo YY. Regulation of breast tumorigenesis through acid sensors. Oncogene. PMID 26686084 DOI: 10.1038/Onc.2015.477  0.435
2015 Huang J, Zhang A, Ho TT, Zhang Z, Zhou N, Ding X, Zhang X, Xu M, Mo YY. Linc-RoR promotes c-Myc expression through hnRNP I and AUF1. Nucleic Acids Research. PMID 26656491 DOI: 10.1093/Nar/Gkv1353  0.38
2015 Wu K, Fukuda K, Xing F, Zhang Y, Sharma S, Liu Y, Chan MD, Zhou X, Qasem SA, Pochampally R, Mo YY, Watabe K. Roles of the cyclooxygenase 2 matrix metalloproteinase 1 pathway in brain metastasis of breast cancer. The Journal of Biological Chemistry. 290: 9842-54. PMID 25691572 DOI: 10.1074/Jbc.M114.602185  0.308
2015 Vallabhaneni KC, Penfornis P, Dhule S, Guillonneau F, Adams KV, Mo YY, Xu R, Liu Y, Watabe K, Vemuri MC, Pochampally R. Extracellular vesicles from bone marrow mesenchymal stem/stromal cells transport tumor regulatory microRNA, proteins, and metabolites. Oncotarget. 6: 4953-67. PMID 25669974 DOI: 10.18632/Oncotarget.3211  0.303
2015 Xing F, Sharma S, Liu Y, Mo YY, Wu K, Zhang YY, Pochampally R, Martinez LA, Lo HW, Watabe K. miR-509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF-α Oncogene. PMID 25659578 DOI: 10.1038/Onc.2014.412  0.443
2015 Ho TT, Zhou N, Huang J, Koirala P, Xu M, Fung R, Wu F, Mo YY. Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines. Nucleic Acids Research. 43: e17. PMID 25414344 DOI: 10.1093/Nar/Gku1198  0.629
2015 Koirala P, Zou D, Mo Y. Long non-coding RNAs as key regulators of cancer metastasis Journal of Cancer Metastasis and Treatment. 2: 0. DOI: 10.4103/2394-4722.171829  0.403
2015 Gupta SC, Mo Y. Abstract 168: MALAT1 is crucial for epithelial-mesenchymal transition of breast cancer cells in acidic microenvironment Cancer Research. 75: 168-168. DOI: 10.1158/1538-7445.Am2015-168  0.455
2015 Ho T, Zhou N, Huang J, Koirala P, Xu M, Fung R, Wu F, Mo Y. Abstract 167: Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines Cancer Research. 75: 167-167. DOI: 10.1158/1538-7445.Am2015-167  0.639
2015 Singh R, Mo Y. Abstract 156: LncRNA BC200 is induced by estradiol and regulates apoptosis in MCF-7 breast cancer cells Cancer Research. 75: 156-156. DOI: 10.1158/1538-7445.Am2015-156  0.456
2014 Gupta SC, Singh R, Pochampally R, Watabe K, Mo YY. Acidosis promotes invasiveness of breast cancer cells through ROS-AKT-NF-κB pathway. Oncotarget. 5: 12070-82. PMID 25504433 DOI: 10.18632/Oncotarget.2514  0.401
2014 Singh R, Pochampally R, Watabe K, Lu Z, Mo YY. Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer. Molecular Cancer. 13: 256. PMID 25428807 DOI: 10.1186/1476-4598-13-256  0.509
2014 Zhang A, Xu M, Mo YY. Role of the lncRNA-p53 regulatory network in cancer. Journal of Molecular Cell Biology. 6: 181-91. PMID 24721780 DOI: 10.1093/Jmcb/Mju013  0.44
2014 Huang J, Zhou N, Watabe K, Lu Z, Wu F, Xu M, Mo YY. Long non-coding RNA UCA1 promotes breast tumor growth by suppression of p27 (Kip1). Cell Death & Disease. 5: e1008. PMID 24457952 DOI: 10.1038/cddis.2013.541  0.651
2014 Zhou N, Mo Y. Abstract 461: Modulation of estrogen receptor (ER) and androgen receptor (AR) by a modified CRISPR-Cas9 system Cancer Research. 74: 461-461. DOI: 10.1158/1538-7445.Am2014-461  0.36
2014 Huang J, Mo Y. Abstract 3537: Suppression of miR-145 by long noncoding RNA RoR in colon cancer Cancer Research. 74: 3537-3537. DOI: 10.1158/1538-7445.Am2014-3537  0.511
2014 Wang C, Redfield S, Mao J, Mo Y, Zhou X. Abstract 3011: Differential expressions of lysophospholipid receptors (LPRs) in benign and malignant tissues from various human system/organs Cancer Research. 74: 3011-3011. DOI: 10.1158/1538-7445.Am2014-3011  0.314
2014 Gupta SC, Mo Y. Abstract 1101: Acidosis-induced NF-κB promotes cell invasion in breast cancer Cancer Research. 74: 1101-1101. DOI: 10.1158/1538-7445.Am2014-1101  0.414
2013 Gupta SC, Francis SK, Nair MS, Mo YY, Aggarwal BB. Azadirone, a limonoid tetranortriterpene, induces death receptors and sensitizes human cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through a p53 protein-independent mechanism: evidence for the role of the ROS-ERK-CHOP-death receptor pathway. The Journal of Biological Chemistry. 288: 32343-56. PMID 24078627 DOI: 10.1074/jbc.M113.455188  0.316
2013 Zhang Z, Zhu Z, Watabe K, Zhang X, Bai C, Xu M, Wu F, Mo YY. Negative regulation of lncRNA GAS5 by miR-21. Cell Death and Differentiation. 20: 1558-68. PMID 23933812 DOI: 10.1038/cdd.2013.110  0.649
2013 Mo YY, Tang H, Miele L. Notch-associated microRNAs in cancer. Current Drug Targets. 14: 1157-66. PMID 23834150 DOI: 10.2174/13894501113149990188  0.41
2013 Liu Q, Huang J, Zhou N, Zhang Z, Zhang A, Lu Z, Wu F, Mo YY. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Research. 41: 4976-87. PMID 23558749 DOI: 10.1093/Nar/Gkt182  0.692
2013 Xing F, Kobayashi A, Okuda H, Watabe M, Pai SK, Pandey PR, Hirota S, Wilber A, Mo YY, Moore BE, Liu W, Fukuda K, Iiizumi M, Sharma S, Liu Y, et al. Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain. Embo Molecular Medicine. 5: 384-96. PMID 23495140 DOI: 10.1002/Emmm.201201623  0.377
2013 Okuda H, Xing F, Pandey PR, Sharma S, Watabe M, Pai SK, Mo YY, Iiizumi-Gairani M, Hirota S, Liu Y, Wu K, Pochampally R, Watabe K. miR-7 suppresses brain metastasis of breast cancer stem-like cells by modulating KLF4. Cancer Research. 73: 1434-44. PMID 23384942 DOI: 10.1158/0008-5472.Can-12-2037  0.481
2013 Singh R, Mo YY. Role of microRNAs in breast cancer. Cancer Biology & Therapy. 14: 201-12. PMID 23291983 DOI: 10.4161/Cbt.23296  0.378
2013 Zhang A, Zhou N, Huang J, Liu Q, Fukuda K, Ma D, Lu Z, Bai C, Watabe K, Mo YY. The human long non-coding RNA-RoR is a p53 repressor in response to DNA damage. Cell Research. 23: 340-50. PMID 23208419 DOI: 10.1038/Cr.2012.164  0.347
2013 Zhou N, Mo Y. Abstract 5286: A genetic selection system for microRNA targets identification and validation. Cancer Research. 73: 5286-5286. DOI: 10.1158/1538-7445.Am2013-5286  0.434
2013 Zhang J, Mo Y. Abstract 4224: A quick and easy way of assembling TALE/TALEN modules for genetic modifications in mammalian cells . Cancer Research. 73: 4224-4224. DOI: 10.1158/1538-7445.Am2013-4224  0.349
2013 Xing F, Okuda H, Kobayashi A, Pandey PR, Sharma S, Mo Y, Liu Y, Wu K, Watabe K. Abstract 3084: miR509 suppresses brain metastasis of breast cancer cells by modulating RhoC and TNF alpha. Cancer Research. 73: 3084-3084. DOI: 10.1158/1538-7445.Am2013-3084  0.42
2013 Huang J, Mo Y. Abstract 1827: HnRNP I interacts with lncRNA UCA1 and regulates its stability. Cancer Research. 73: 1827-1827. DOI: 10.1158/1538-7445.Am2013-1827  0.451
2012 Xu M, Mo YY. The Akt-associated microRNAs. Cellular and Molecular Life Sciences : Cmls. 69: 3601-12. PMID 22936352 DOI: 10.1007/S00018-012-1129-8  0.444
2012 Mo YY. MicroRNA regulatory networks and human disease. Cellular and Molecular Life Sciences : Cmls. 69: 3529-31. PMID 22926413 DOI: 10.1007/S00018-012-1123-1  0.527
2012 Sachdeva M, Liu Q, Cao J, Lu Z, Mo YY. Negative regulation of miR-145 by C/EBP-β through the Akt pathway in cancer cells. Nucleic Acids Research. 40: 6683-92. PMID 22495929 DOI: 10.1093/Nar/Gks324  0.422
2012 Liu Z, Yan R, Al-Salman A, Shen Y, Bu Y, Ma J, Luo DX, Huang C, Jiang Y, Wilber A, Mo YY, Huang MC, Zhao Y, Cao D. Epidermal growth factor induces tumour marker AKR1B10 expression through activator protein-1 signalling in hepatocellular carcinoma cells. The Biochemical Journal. 442: 273-82. PMID 22329800 DOI: 10.1042/Bj20111322  0.352
2012 Liu W, Xing F, Iiizumi-Gairani M, Okuda H, Watabe M, Pai SK, Pandey PR, Hirota S, Kobayashi A, Mo YY, Fukuda K, Li Y, Watabe K. N-myc downstream regulated gene 1 modulates Wnt-β-catenin signalling and pleiotropically suppresses metastasis. Embo Molecular Medicine. 4: 93-108. PMID 22246988 DOI: 10.1002/Emmm.201100190  0.378
2012 Zhou N, Mo YY. Roles of microRNAs in cancer stem cells. Frontiers in Bioscience (Scholar Edition). 4: 810-8. PMID 22202092 DOI: 10.2741/S301  0.461
2012 Huang J, Mo YY. Role of microRNAs in leukemia stem cells. Frontiers in Bioscience (Scholar Edition). 4: 799-809. PMID 22202091 DOI: 10.2741/S300  0.354
2012 Wu F, Mo Y. Abstract A19: Profiling long noncoding RNA expression in cancer cells by real-time PCR arrays Cancer Research. 72: A19-A19. DOI: 10.1158/1538-7445.Nonrna12-A19  0.664
2012 Zhou N, Mo Y. Abstract 5025: Regulation of miR-145 expression by Foxo3a, C/EBP-β and p53 in cancer cells Cancer Research. 72: 5025-5025. DOI: 10.1158/1538-7445.Am2012-5025  0.474
2011 Xing F, Okuda H, Watabe M, Kobayashi A, Pai SK, Liu W, Pandey PR, Fukuda K, Hirota S, Sugai T, Wakabayshi G, Koeda K, Kashiwaba M, Suzuki K, Chiba T, ... Mo YY, et al. Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells. Oncogene. 30: 4075-86. PMID 21499308 DOI: 10.1038/Onc.2011.122  0.442
2011 Chen CF, He X, Arslan AD, Mo YY, Reinhold WC, Pommier Y, Beck WT. Novel regulation of nuclear factor-YB by miR-485-3p affects the expression of DNA topoisomerase IIα and drug responsiveness. Molecular Pharmacology. 79: 735-41. PMID 21252292 DOI: 10.1124/mol.110.069633  0.328
2011 Pandey PR, Okuda H, Watabe M, Pai SK, Liu W, Kobayashi A, Xing F, Fukuda K, Hirota S, Sugai T, Wakabayashi G, Koeda K, Kashiwaba M, Suzuki K, Chiba T, ... Mo YY, et al. Resveratrol suppresses growth of cancer stem-like cells by inhibiting fatty acid synthase. Breast Cancer Research and Treatment. 130: 387-98. PMID 21188630 DOI: 10.1007/S10549-010-1300-6  0.425
2011 Gupta A, Mo YY. Detection of microRNAs in cultured cells and paraffin-embedded tissue specimens by in situ hybridization. Methods in Molecular Biology (Clifton, N.J.). 676: 73-83. PMID 20931391 DOI: 10.1007/978-1-60761-863-8_6  0.422
2011 Liu W, Furuta E, Shindo K, Watabe M, Xing F, Pandey PR, Okuda H, Pai SK, Murphy LL, Cao D, Mo YY, Kobayashi A, Iiizumi M, Fukuda K, Xia B, et al. Cacalol, a natural sesquiterpene, induces apoptosis in breast cancer cells by modulating Akt-SREBP-FAS signaling pathway. Breast Cancer Research and Treatment. 128: 57-68. PMID 20665104 DOI: 10.1007/S10549-010-1076-8  0.445
2011 Pandey PR, Okuda H, Misako W, Pai SK, Liu W, Kobayashi A, Xing F, Fukuda K, Hirota S, Sugai T, Wakabayashi G, Koeda K, Kashiwaba M, Suzuki K, Chiba T, ... ... Mo Y, et al. Abstract 979: Upregulation of lipogenic genes, SREBP-1, ACLY, ACC-1 and FAS, confer proliferation and survival advantages to cancer stem-like cells in ductal carcinoma in situ Cancer Research. 71: 979-979. DOI: 10.1158/1538-7445.Am2011-979  0.436
2010 Ng WL, Yan D, Zhang X, Mo YY, Wang Y. Over-expression of miR-100 is responsible for the low-expression of ATM in the human glioma cell line: M059J. Dna Repair. 9: 1170-5. PMID 20869334 DOI: 10.1016/J.Dnarep.2010.08.007  0.453
2010 Yan D, Ng WL, Zhang X, Wang P, Zhang Z, Mo YY, Mao H, Hao C, Olson JJ, Curran WJ, Wang Y. Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. Plos One. 5: e11397. PMID 20617180 DOI: 10.1371/Journal.Pone.0011397  0.333
2010 Sachdeva M, Mo YY. miR-145-mediated suppression of cell growth, invasion and metastasis. American Journal of Translational Research. 2: 170-80. PMID 20407606  0.403
2010 Sachdeva M, Mo YY. Stroma-mediated expression of estrogen and its role in cancer. Frontiers in Bioscience (Landmark Edition). 15: 237-48. PMID 20036818 DOI: 10.2741/3618  0.366
2010 Zhu S, Sachdeva M, Wu F, Lu Z, Mo YY. Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner. Oncogene. 29: 1763-72. PMID 20023705 DOI: 10.1038/Onc.2009.459  0.689
2010 Sachdeva M, Mo YY. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Research. 70: 378-87. PMID 19996288 DOI: 10.1158/0008-5472.Can-09-2021  0.455
2010 Sachdeva M, Zhu S, Mo Y. MicroRNA-21 as a Novel Therapeutic Target Current Cancer Therapy Reviews. 6: 41-50. DOI: 10.2174/157339410790596452  0.301
2010 Ho T, He X, Arslan AD, Mo Y, Beck WT. Abstract 2073: Changes in microRNA expression in response to short-term chemotherapeutic exposure is associated with transient anticancer drug resistance Cancer Research. 70: 2073-2073. DOI: 10.1158/1538-7445.Am10-2073  0.368
2009 Wu H, Mo YY. Targeting miR-205 in breast cancer. Expert Opinion On Therapeutic Targets. 13: 1439-48. PMID 19839716 DOI: 10.1517/14728220903338777  0.505
2009 Jiang Q, Feng MG, Mo YY. Systematic validation of predicted microRNAs for cyclin D1. Bmc Cancer. 9: 194. PMID 19538740 DOI: 10.1186/1471-2407-9-194  0.36
2009 Huang TH, Wu F, Loeb GB, Hsu R, Heidersbach A, Brincat A, Horiuchi D, Lebbink RJ, Mo YY, Goga A, McManus MT. Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion. The Journal of Biological Chemistry. 284: 18515-24. PMID 19419954 DOI: 10.1074/Jbc.M109.006676  0.669
2009 Wu H, Zhu S, Mo YY. Suppression of cell growth and invasion by miR-205 in breast cancer. Cell Research. 19: 439-48. PMID 19238171 DOI: 10.1038/Cr.2009.18  0.485
2009 Wu F, Zhu S, Ding Y, Beck WT, Mo YY. MicroRNA-mediated regulation of Ubc9 expression in cancer cells. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1550-7. PMID 19223510 DOI: 10.1158/1078-0432.Ccr-08-0820  0.648
2009 Sachdeva M, Zhu S, Wu F, Wu H, Walia V, Kumar S, Elble R, Watabe K, Mo YY. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proceedings of the National Academy of Sciences of the United States of America. 106: 3207-12. PMID 19202062 DOI: 10.1073/Pnas.0808042106  0.645
2008 Furuta E, Pai SK, Zhan R, Bandyopadhyay S, Watabe M, Mo YY, Hirota S, Hosobe S, Tsukada T, Miura K, Kamada S, Saito K, Iiizumi M, Liu W, Ericsson J, et al. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Research. 68: 1003-11. PMID 18281474 DOI: 10.1158/0008-5472.Can-07-2489  0.423
2008 Zhu S, Wu H, Wu F, Nie D, Sheng S, Mo YY. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Research. 18: 350-9. PMID 18270520 DOI: 10.1038/Cr.2008.24  0.658
2007 Wu H, Dinh A, Mo YY. Generation of shRNAs from randomized oligonucleotides. Biological Procedures Online. 9: 9-17. PMID 18213360 DOI: 10.1251/Bpo129  0.348
2007 Wu F, Chiocca S, Beck WT, Mo YY. Gam1-associated alterations of drug responsiveness through activation of apoptosis. Molecular Cancer Therapeutics. 6: 1823-30. PMID 17575111 DOI: 10.1158/1535-7163.Mct-06-0771  0.561
2007 Wu F, Stutzman A, Mo YY. Notch signaling and its role in breast cancer. Frontiers in Bioscience : a Journal and Virtual Library. 12: 4370-83. PMID 17485381 DOI: 10.2741/2394  0.631
2007 Zhu S, Si ML, Wu H, Mo YY. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). The Journal of Biological Chemistry. 282: 14328-36. PMID 17363372 DOI: 10.1074/Jbc.M611393200  0.431
2007 Wu F, Mo YY. Ubiquitin-like protein modifications in prostate and breast cancer. Frontiers in Bioscience : a Journal and Virtual Library. 12: 700-11. PMID 17127330 DOI: 10.2741/2094  0.645
2007 Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. miR-21-mediated tumor growth. Oncogene. 26: 2799-803. PMID 17072344 DOI: 10.1038/sj.onc.1210083  0.372
2006 Lu Z, Wu H, Mo YY. Regulation of bcl-2 expression by Ubc9. Experimental Cell Research. 312: 1865-75. PMID 16566921 DOI: 10.1016/J.Yexcr.2006.02.017  0.413
2005 Dinh A, Mo YY. Alternative approach to generate shRNA from cDNA. Biotechniques. 38: 629-32. PMID 15884681 DOI: 10.2144/05384Rn02  0.303
2005 Mo YY, Yu Y, Theodosiou E, Ee PL, Beck WT. A role for Ubc9 in tumorigenesis. Oncogene. 24: 2677-83. PMID 15735760 DOI: 10.1038/sj.onc.1208210  0.336
Show low-probability matches.